Objectif
The anti-decubitus system JUMPAIR will benefit a large number of patients who are suffering of decubitus ulcers (DeU) or
they are running the risk to suffer it by remotely monitor ulcers biomarkers to improve early diagnoses through DeU
prevention, and then through an advanced DeU treatment providing alerts at critical situations by the adoption of smart
relevant ICT solutions for the health, well-being and well-ageing of patients. Additionally, JUMPAIR will also offer a
rehabilitation programme for patients who suffered of DeU during the bedding in their house or in a hospital. The final
product will contribute to prevent DeU and to improve healthcare expenditure containment avoiding unnecessary
hospitalizations and therapeutic treatments. We believe that there is an unmet need in that field to deliver new and more
efficient care to European citizens, and the final systems allows a preventive and therapeutic care of DeU having a great
impact for physicians and patients who deal with this critical DeU disease.
Champ scientifique
Mots‑clés
Programme(s)
- H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being Main Programme
- H2020-EU.3.1.4. - Active ageing and self-management of health
- H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)
- H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument
- H2020-EU.3.1.6. - Health care provision and integrated care
Régime de financement
SME-2 - SME instrument phase 2Coordinateur
33040 Pradamano Ud
Italie
L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention.